1.Jurjevic Z., Peterson SW., Horn BW. Aspergillus section Versicolores: nine new species and multilocus DNA sequence based phylogeny. IMA Fungus. 2012. 3:59–79.
2.Van Der Linden JW., Warris A., Verweij PE. Aspergillus species intrinsically resistant to antifungal agents. Med Mycol. 2011. 49(Suppl 1):S82–9.
3.Clinical and Laboratory Standards Institute. Interpretive Criteria for Microorganism Identification by DNA Target Sequencing; Approved Guideline. Document MM18-A. Wayne PA. Clinical and Laboratory Standards Institute. 2008.
4.Wang S., Zinderman C., Wise R., Braun M. Infections and human tissue transplants: review of FDA MedWatch reports 2001-2004. Cell Tissue Bank. 2007. 8:211–9.
Article
5.Fan YD., Van Hoeck B., Holovska V., Jashari R. Evaluation of decontamination process of heart valve and artery tissues in European Homograft Bank (EHB): a retrospective study of 1,055 cases. Cell Tissue Bank. 2012. 13:297–304.
Article
6.Villalba R., Mirabet V., Rendal E., González AI., Solves P., Andión C, et al. Microbiological analysis of cryopreserved human heart valves after storage: a survey of 3 banks in Spain. Cell Tissue Bank. 2009. 10:345–9.
Article
7.Soo A., Healy DG., El-Bashier H., Shaw S., Wood AE. Quality control in homograft valve processing: when to screen for microbiological contamination? Cell Tissue Bank. 2011. 12:185–90.
Article
8.Alastruey-Izquierdo A., Mellado E., Cuenca-Estrella M. Current section and species complex concepts in Aspergillus: recommendations for routine daily practice. Ann N Y Acad Sci. 2012. 1273:18–24.
9.Larone DH. Medically important fungi. a guide to identification. 5th ed.Washington DC: ASM Press;2011.